Literature DB >> 15622558

Breast cancer risks for BRCA1/2 carriers.

Sholom Wacholder, Jeffery P Struewing, Patricia Hartge, Mark H Greene, Margaret A Tucker.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15622558

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  6 in total

1.  Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.

Authors:  Ivana Antonucci; Martina Provenzano; Luca Sorino; Michela Balsamo; Gitana Maria Aceto; Pasquale Battista; David Euhus; Ettore Cianchetti; Patrizia Ballerini; Clara Natoli; Giandomenico Palka; Liborio Stuppia
Journal:  J Hum Genet       Date:  2016-12-08       Impact factor: 3.172

2.  MicroRNA binding site polymorphisms as biomarkers of cancer risk.

Authors:  Cory Pelletier; Joanne B Weidhaas
Journal:  Expert Rev Mol Diagn       Date:  2010-09       Impact factor: 5.225

3.  Risk-reduction surgery decisions in high-risk women seen for genetic counseling.

Authors:  Jessica A Ray; Lois J Loescher; Molly Brewer
Journal:  J Genet Couns       Date:  2005-12       Impact factor: 2.537

4.  BRCA1 and BRCA2 families and the risk of skin cancer.

Authors:  Ophira M Ginsburg; Charmaine Kim-Sing; William D Foulkes; Parviz Ghadirian; Henry T Lynch; Ping Sun; Steven A Narod
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

5.  BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.

Authors:  Alexis D Bakos; Sadie P Hutson; Jennifer T Loud; June A Peters; Ruthann M Giusti; Mark H Greene
Journal:  Health Expect       Date:  2008-09       Impact factor: 3.377

6.  Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts.

Authors:  Shanbeh Zienolddiny; Aage Haugen; Jenny-Anne Sigstad Lie; Helge Kjuus; Kristine Haugen Anmarkrud; Kristina Kjærheim
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.